Bayforest Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
AI
Bayforest Capital's BIO Position: Q2 2026 in Review
Bayforest Capital opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 682 shares worth $200K. The stake represents 0.19% of the portfolio and ranks #178 among its holdings. This is a return to the name: Bayforest Capital previously reported a position in BIO as recently as Q1 2025.
Bayforest Capital first reported a position in BIO in Q4 2024 and has held it in 3 quarters since. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.
- Bayforest Capital held 682 shares of Bio-Rad Laboratories Class A worth $200K as of Q2 2026.
- Bio-Rad Laboratories Class A was a new Bayforest Capital position in Q2 2026.
- Bio-Rad Laboratories Class A made up 0.19% of Bayforest Capital's portfolio in Q2 2026, its #178 holding.
- Bayforest Capital first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and has held it in 3 quarters since.
- 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.
Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.